|
![]() ![]() | |||
John Muir Health is committed to improving the health of the communities we serve by offering state-of-the-art treatment options through clinical research. Clinical research represents a unique opportunity to improve the survival and quality of life of the patient, and to translate basic research into clinical application.
Our physicians are engaged in a wide variety of clinical trials across different therapeutic areas. All of our clinical research studies have been approved by Institutional Review Boards (IRB) that are set up to protect the interests of human subjects participating in research. The information provided is for general use only. Please contact the number listed for a specific study to get further information.
Learn more about a possible side effect that could affect your quality of life. John Muir Health is participating in a new study to prevent lymphedema in women treated for breast cancer.
More informationYou may be eligible to participate in a national research study sponsored by the National Surgical Adjuvant Bowel and Breast Project (NSABP): NSABP B-42: Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer.
More information